Pediatric SARS, H1N1, MERS, EVALI, and now coronavirus disease (COVID-19) Pneumonia: What radiologists need to know

Alexandra M. Foust, Abbey J. Winant, Winnie C. Chu, Karuna M. Das, Grace S. Phillips, Edward Y. Lee

Research output: Contribution to journalReview articlepeer-review

32 Citations (Scopus)

Abstract

OBJECTIVE. The purpose of this article is to review new pediatric lung disorders-including disorders that have occurred in recent years years such as severe acute respiratory syndrome (SARS), swine-origin influenza A (H1N1), Middle East respiratory syndrome (MERS), e-cigarette or vaping product use-associated lung injury (EVALI), and coronavirus disease (COVID-19) pneumonia-to enhance understanding of the characteristic imaging findings. CONCLUSION. Although the clinical symptoms of SARS, H1N1, MERS, EVALI, and COVID-19 pneumonia in pediatric patients may be nonspecific, some characteristic imaging findings have emerged or are currently emerging. It is essential for radiologists to have a clear understanding of the characteristic imaging appearances of these lung disorders in pediatric patients to ensure optimal patient care.

Original languageEnglish
Pages (from-to)736-744
Number of pages9
JournalAmerican Journal of Roentgenology
Volume215
Issue number3
DOIs
Publication statusPublished - Sep 2020

Keywords

  • COVID-19
  • Coronavirus disease
  • E-cigarette or vaping product use-associated lung injury
  • EVALI
  • H1N1
  • MERS
  • Middle East respiratory syndrome
  • SARS
  • Severe acute respiratory syndrome
  • Swine-origin influenza A
  • Viral pneumonia

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint

Dive into the research topics of 'Pediatric SARS, H1N1, MERS, EVALI, and now coronavirus disease (COVID-19) Pneumonia: What radiologists need to know'. Together they form a unique fingerprint.

Cite this